243 related articles for article (PubMed ID: 10096521)
1. Temporal sequence of transcription of perforin, Fas ligand, and tumor necrosis factor-alpha genes in rejecting skin allografts.
Borson ND; Strausbauch MA; Kennedy RB; Oda RP; Landers JP; Wettstein PJ
Transplantation; 1999 Mar; 67(5):672-80. PubMed ID: 10096521
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis is involved in acute cardiac allograft rejection in rats.
Kageyama Y; Li XK; Suzuki S; Suzuki H; Suzuki K; Kazui T; Harada Y
Ann Thorac Surg; 1998 Jun; 65(6):1604-9. PubMed ID: 9647066
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic pathways in the skin allograft rejection by CD4+ T cells.
Ito A; Minagawa M; Tomiyama K; Ito M; Kawai K
Transplantation; 1999 Jul; 68(1):97-100. PubMed ID: 10428275
[TBL] [Abstract][Full Text] [Related]
4. Antigen-primed CD8+ T cells can mediate resistance, preventing allogeneic marrow engraftment in the simultaneous absence of perforin-, CD95L-, TNFR1-, and TRAIL-dependent killing.
Komatsu M; Mammolenti M; Jones M; Jurecic R; Sayers TJ; Levy RB
Blood; 2003 May; 101(10):3991-9. PubMed ID: 12521999
[TBL] [Abstract][Full Text] [Related]
5. Analysis of effector mechanisms in murine cardiac allograft rejection.
Alexander DZ; Pearson TC; Hendrix R; Ritchie SC; Larsen CP
Transpl Immunol; 1996 Mar; 4(1):46-8. PubMed ID: 8762009
[TBL] [Abstract][Full Text] [Related]
6. Acute rejection of allografted CTL-susceptible leukemia cells from perforin/Fas ligand double-deficient mice.
Nomi H; Tashiro-Yamaji J; Yamamoto Y; Miura-Takeda S; Miyoshi-Higashino M; Takahashi T; Azuma H; Ueda H; Katsuoka Y; Kubota T; Yoshida R
J Immunol; 2007 Aug; 179(4):2180-6. PubMed ID: 17675477
[TBL] [Abstract][Full Text] [Related]
7. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts.
Taylor MA; Ward B; Schatzle JD; Bennett M
Eur J Immunol; 2002 Mar; 32(3):793-9. PubMed ID: 11870623
[TBL] [Abstract][Full Text] [Related]
8. Molecular executors of cell death--differential intrarenal expression of Fas ligand, Fas, granzyme B, and perforin during acute and/or chronic rejection of human renal allografts.
Sharma VK; Bologa RM; Li B; Xu GP; Lagman M; Hiscock W; Mouradian J; Wang J; Serur D; Rao VK; Suthanthiran M
Transplantation; 1996 Dec; 62(12):1860-6. PubMed ID: 8990377
[TBL] [Abstract][Full Text] [Related]
9. In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL.
Lee SH; Bar-Haim E; Machlenkin A; Goldberger O; Volovitz I; Vadai E; Tzehoval E; Eisenbach L
Cancer Gene Ther; 2004 Mar; 11(3):237-48. PubMed ID: 14739939
[TBL] [Abstract][Full Text] [Related]
10. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
[TBL] [Abstract][Full Text] [Related]
11. CD8+ cells are not necessary for allograft rejection or the induction of apoptosis in an experimental model of small intestinal transplantation.
Krams SM; Hayashi M; Fox CK; Villanueva JC; Whitmer KJ; Burns W; Esquivel CO; Martinez OM
J Immunol; 1998 Apr; 160(8):3673-80. PubMed ID: 9558067
[TBL] [Abstract][Full Text] [Related]
12. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
Miura Y; Thoburn CJ; Bright EC; Hess AD
Biol Blood Marrow Transplant; 2004 Mar; 10(3):156-70. PubMed ID: 14993881
[TBL] [Abstract][Full Text] [Related]
13. Islet allograft rejection by contact-dependent CD8+ T cells: perforin and FasL play alternate but obligatory roles.
Sleater M; Diamond AS; Gill RG
Am J Transplant; 2007 Aug; 7(8):1927-33. PubMed ID: 17617855
[TBL] [Abstract][Full Text] [Related]
14. Defining the roles of perforin, Fas/FasL, and tumour necrosis factor alpha in T cell induced mucosal damage in the mouse intestine.
Merger M; Viney JL; Borojevic R; Steele-Norwood D; Zhou P; Clark DA; Riddell R; Maric R; Podack ER; Croitoru K
Gut; 2002 Aug; 51(2):155-63. PubMed ID: 12117872
[TBL] [Abstract][Full Text] [Related]
15. Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms.
Kafrouni MI; Brown GR; Thiele DL
J Immunol; 2001 Aug; 167(3):1566-74. PubMed ID: 11466378
[TBL] [Abstract][Full Text] [Related]
16. The Fas/Fas ligand pathway is important for optimal tumor regression in a mouse model of CTL adoptive immunotherapy of experimental CMS4 lung metastases.
Caldwell SA; Ryan MH; McDuffie E; Abrams SI
J Immunol; 2003 Sep; 171(5):2402-12. PubMed ID: 12928387
[TBL] [Abstract][Full Text] [Related]
17. In vivo analysis of adenovirus-specific cytotoxic T lymphocyte response in mice deficient in CD28, fas ligand, and perforin.
Chen J; Hsu HC; Zajac AJ; Wu Q; Yang P; Xu X; McPherson SA; Li J; Curiel DT; Mountz JD
Hum Gene Ther; 2006 Jun; 17(6):669-82. PubMed ID: 16776575
[TBL] [Abstract][Full Text] [Related]
18. Intragraft activation of genes encoding cytotoxic T lymphocyte effector molecules precedes the histological evidence of rejection in human cardiac transplantation.
Shulzhenko N; Morgun A; Zheng XX; Diniz RV; Almeida DR; Ma N; Strom TB; Gerbase-DeLima M
Transplantation; 2001 Nov; 72(10):1705-8. PubMed ID: 11726838
[TBL] [Abstract][Full Text] [Related]
19. The granule exocytosis and Fas/FasLigand pathways at the time of transplantation and during borderline and acute rejection of human renal allografts.
Carstens J; Markussen N; Madsen M
Transplant Proc; 2005 Oct; 37(8):3294-7. PubMed ID: 16298578
[TBL] [Abstract][Full Text] [Related]
20. Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand.
Liu AN; Mohammed AZ; Rice WR; Fiedeldey DT; Liebermann JS; Whitsett JA; Braciale TJ; Enelow RI
Am J Respir Cell Mol Biol; 1999 May; 20(5):849-58. PubMed ID: 10226053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
